Prevention of restenosis: Future directions

Trends in Cardiovascular Medicine

Volumn 7, Issue 3, 1997, Pages 90-94

  Bauters, Christophe ^a   Van Belle, Eric ^a   Meurice, Thibaud ^a   Letourneau, Thierry ^a   Lablanche, Jean Marc ^a   Bertrand, Michel E ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; VASCULOTROPIN;

ARTERY INTIMA PROLIFERATION; BALLOON CATHETER; CORONARY ARTERY OBSTRUCTION; HUMAN; INFUSION PUMP; INTRAARTICULAR DRUG ADMINISTRATION; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; SHORT SURVEY; TISSUE REPAIR; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

EID: 0030926472     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00013-3     Document Type: Article

References (40)

1. Asahara T, Bauters C, Pastore C, et al.: 1995. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91:2793-2801.
2. Austin GE, Norman NB, Hollman J, Tabei S, Phillips VF: 1985. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 6:369-375.
3. Bauters C, Lablanche JM, Renaud N, Mc Fadden EP, Hamon M, Bertrand ME: 1996. Morphologic changes after percutaneous transluminal coronary angioplasty of unstable plaques: insights from serial angioscopic follow-up. Eur Heart J 17:1554-1559.
4. Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI: 1994. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest 93:820-828.
5. Camenzind E, Reys A, Ligthart J, et al.: 1995. Local intracoronary delivery of heparin and of a somatostatin analogue (octreotide) following angioplasty in man: evaluation of efficacy of delivery by radio-isotopic technique [abst]. J Am Coll Cardiol (Suppl):285A.
6. De Scheerder I, Wilczek K, Van Dorpe J, et al.: 1994. Angiopeptin loaded stents inhibit the neointimal reaction induced by polymer coated stents implanted in porcine coronary arteries [abst]. Circulation 90:1-597.
7. Emanuellson H, Beatt KJ, Bagger JP, et al.: 1995. Long-term effects of angiopeptin treatment in coronary angioplasty: reduction of clinical events but not angiographic restenosis. Circulation 91:1689-1696.
8. Falk E: 1985. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and or sudden death. Circulation 71:699-708.
9. Fischman DL, Leon MB, Bairn DS, et al.: 1994. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496-501.
10. Fram DB, Aretz TA, Mitchel JF, et al.: 1992. Localized intramural delivery of a marker agent during balloon angioplasty: a new technique using hydrogel-coated balloons and active diffusion [abst]. Circulation 86:1-380.
11. Franklin SM, Faxon DP: 1993. Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials. Coron Artery Dis 4:232-242.
12. Garg UC, Hassid A: 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic-guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777.
13. Gruentzig A, Senning A, Siegenthaler WE: 1979. Nonoperative dilatation of coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 301:61-68.
14. Herrman JPR, Hermans WRM, Vos J, Serruys PW: 1993. Pharmacological approaches to the prevention of restenosis following angioplasty: the search for the holy grail? (Part I). Drugs 46:18-52.
15. Isner JM, Kearney M, Bauters C, et al.: 1994. Use of human tissue specimens obtained in vivo by directional atherectomy to study restenosis and related human vascular disorders. Trends Cardiovasc Med 4:213-221.
16. Johnson DE, Hinohara T, Selmon MR, Braden LJ, Simpson JB: 1990. Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathologic study. J Am Coll Cardiol 15:419-425.
17. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP: 1994. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation 89:2809-2815.
18. Karas SP, Gravanis MB, Robinson KA, Anderberg A, Hearn JA, King SB: 1990. Comparison of the response to coronary artery balloon injury and stenting in swine: an animal model of restenosis [abst]. Circulation 82(Suppl 3):III-497.
19. Kent KM, Williams DO, Cassagneau B, et al.: 1993. Double-blind, controlled trial of the effect of angiopeptin on coronary restenosis following balloon angioplasty [abst]. Circulation 88(Suppl 1): 1-506.
20. Kovach JA, Mintz GS, Kent KM, et al.: 1993. Serial intravascular ultrasound studies indicates that chronic recoil is an important mechanism of restenosis following transcatheter therapy [abst]. J Am Coll Cardiol 21:484A.
21. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM: 1995. Restenosis after experimental angioplasty: intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res 76:996-1002.
22. Liu MW, Roubin GS, King III SB: 1989. Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia. Circulation 79:1374-1387.
23. March KL, Mohanraj S, Ho P, Wilenski RL, Hathaway DR: 1992. Biodegradable microspheres containing a colchicine analog inhibit DNA synthesis in vascular smooth muscle cells [abst]. Circulation 86:1-381.
24. McBride W, Lange RA, Hillis LD: 1988. Restenosis after successful coronary angioplasty: pathophysiology and prevention. N Engl J Med 318:1734-1737.
25. Mintz GS, Douek PC, Bonner RF, et al.: 1993. Intravascular ultrasound comparison of de novo and restenotic coronary artery lesions [abst]. J Am Coll Cardiol 21:118A.
26. Mintz GS, Popma JJ, Pichard AD, et al.: 1995. Differing mechanisms of late arterial responses to transcatheter therapy: a serial quantitative angiographic and intravascular ultrasound study [abst]. Eur Heart J (Suppl):385.
27. Ohara T, Nanto S, Asada S, Komamura K, Wang DY: 1988. Ultrastructural study of proliferating and migrating smooth muscle cells at the site of PTCA as an explanation for restenosis [abst]. Circulation 78(Suppl 2):90.
28. Popma JJ, Califf RM, Topol EJ: 1991. Clinical trials of restenosis after coronary angioplasty. Circulation 84:1426-1436.
29. Post MJ, Borst C, Kuntz RE: 1994. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty: a study in the normal rabbit and in the hypercholesterolemic Yucatan micropig. Circulation 89:2816-2821.
30. Santoian EC, Schneider JE, Gravanis MB, et al.: 1993. Angiopeptin inhibits intimal hyperplasia after angioplasty in porcine coronary arteries. Circulation 88:11-14.
31. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR: 1990. Restenosis after balloon angioplasty: a practical proliferative model in porcine coronary arteries. Circulation 82:2190-2200.
32. Schwartz SM, deBlois D, O'Brien ERM: 1995. The intima: soil for atherosclerosis and restenosis. Circ Res 77:445-465.
33. Scott-Burden T, Vanhoutte PM: 1993. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation 87(Suppl V):V-51-V-55.
34. Serruys PW, de Jaegere P, Kiemeneij F, et al.: 1994. A comparison of balloon-expandablestent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489-495.
35. Simons M, Edelman ER, DeKeyser JL, Langer R, Rosenberg RD: 1992. Antisense c-myb oligonucleotides inhibit arterial smooth muscle cell accumulation in vivo. Nature 359:67-70.
36. Steg PG, Feldman L, Scoazec JY, et al.: 1994. Percutaneous delivery of adenovirus for arterial gene transfer of endothelial and smooth muscle cells. Circulation 90:1648-1656.
37. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T: 1991. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty: an histochemical analysis of the cellular composition. Circulation 83: 1327-1332.
38. Von der Leyen H, Gibbons GH, Morishita R, et al.: 1994. In vivo gene transfer of nitric oxide synthase inhibits neointima formation in injured rat carotid arteries [abst]. Eur Heart J 15:426.
39. Wilenski RL, March KL, Hathaway DR: 1991. Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplasty. Am Heart J 122:1136-1141.
40. Wolinski H, Thung SN: 1990. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol 15:475-481.